Acute respiratory distress syndrome (ARDS) is a lethal respiratory
disease, wherein lungs cannot adequately deliver oxygen to the vital
body organs. Pneumonia, acute pancreatitis, inhalation of smoke, or
chemicals and certain conditions could result in inflammation of
lungs. Due to inflammation of lungs, fluid from surrounding blood
vessels enter the air sacks of the lungs, resulting in difficulty in
breathing. This condition is known as acute respiratory distress
syndrome or ARDS.
Request Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43673
The global acute respiratory distress syndrome devices market is
primarily driven by increase in number of cases of ARDS, rise in
diagnosis and treatment rates, surge in awareness about ARDS, and
improvement in health care infrastructure. However, high cost of
diagnostic and therapeutic devices and stringent regulatory landscape
are likely to restrain the global acute respiratory distress syndrome
devices market during the forecast period. Increase in R&D
spending, technological advancements, and government initiatives to
educate people about ARDS are expected to boost the growth of the
global market.
Based on device type, the global acute respiratory distress syndrome
devices market can be segmented into therapeutic devices and
diagnostic & monitoring devices. The therapeutic devices segment
can be categorized into mechanical ventilators, drug delivery
devices, PAP, and others. The same market is further classified into
non-invasive ventilator and invasive ventilator, by mechanical
ventilators. In terms of drug delivery, the market can be bifurcated
into nebulizers and humidifiers. In addition, the ARDS devices market
has been categorized into devices and disposables sub-segments. The
diagnostic & monitoring devices segment can be divided into pulse
oximeters, spirometers, capnography devices, blood gas analyzers, and
others. Based on end-user, the market can be classified into
hospitals, independent clinics, and others.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=43673
Geographically, the global acute respiratory distress syndrome
devices market can be segmented into North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa. Around 60 in
100,000 people, or 150,000 people per year, suffer from ARDS and
70,000 people succumb to the disease in the U.S. each year. Over 50
people in 100,000 are affected by ARDS and 15 in 100,000 per year die
from ARDS in Canada. The ARDS scenario in Western Europe is similar
to North America. Around 60 in 100,000 people per year suffer from
ARDS in Western Europe (the U.K., Germany, France, Spain, and Italy),
whereas over 70 in 100,000 people per year suffer from ARDS in
Eastern Europe (Romania, Bulgaria, Hungary, Poland, and Russia).
However, North America and Europe held major market shares in 2017.
The share of ARDS market in those two countries are anticipated to
project by significant growth rates during the forecast period, owing
to increase in number of ARDS cases in the regions, high diagnosis
and treatment rates of ARDS, strong health care infrastructure, and
favorable health care reimbursement. Incidence of ARDS is low in Asia
Pacific. Around 45 in 100,000 people per year suffer from ARDS in the
region. Asia Pacific is projected to account for the third largest
market share in 2017. The market in the region is anticipated to
expand at the fastest CAGR during the forecast period due to large
population developing health care infrastructure, participation of
domestic players, and presence of market leaders. Low diagnosis and
treatment rates of ARDS, less awareness about ARDS, and inadequate
health care infrastructure are likely to restrain the ARDS devices
market in Latin America and Middle East & Africa during the
forecast period.
Report Overview @
https://www.transparencymarketresearch.com/acute-respiratory-distress-syndrome-devices-market.html
Key players in the global acute respiratory distress syndrome devices
market are ResMed, Phillips, GE Healthcare, Hamilton Medical AG,
Masimo Corporation, Nonin Medical, BPL Medical Technologies, Smiths
Medical, and Beurer GmbH, among others.
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment